Making a dagger or giant knife fit for 2020 with a real murder hornet cast in epoxy resin. This project embodies a unique ...

UBS remains bullish on Eli Lilly’s future thanks to surging demand for its obesity and diabetes treatments. UBS predicts Zepbound sales could exceed market expectations by roughly 15%. Meanwhile, ...

Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy. On June 27, UBS kept its Buy rating ...

CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

The Siren’s Curse left riders in a vertical position for about 10 minutes on June 28, the Akron Beacon Journal reported.

Jury reaches partial verdict in Sean Combs trial, unable to reach verdict on Count One Republican Senator tells House not to ...

A Detroit man’s last wish was fulfilled as a helicopter dropped money and rose petals over part of the Motor City. Darrell ...

While Novo Nordisk stock has underperformed since my Strong Buy rating four months ago, the long-term investment thesis ...

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.